ClinicalTrials.gg
RecruitingNCT07190976Updated Sep 24, 2025

The Value of EEG in Stroke Units

An observational study in Epilepsy, sponsored by Attikon Hospital. Recruiting at 1 site in Greece. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-24.

Sponsored by Attikon Hospital · Observational

From the registry’s dates

  • Started Mar 2024; still recruiting 2 years 8 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

Τhe aim of the study is to investigate the role of EEG both in predicting epileptogenesis in patients with acute stroke and in detecting and clarifying the clinical significance of subclinical epileptic seizures in a stroke unit. More specifically, the performance of routine EEG in patients with ischemic or hemorrhagic stroke who are hospitalized in the Stroke Unit within the first days after the event, regardless of the presence of clinical indications, and the identification of risk factors for the early development of epilepsy in the course of these patients' disease constitute the central research question. The identification of patients with subclinical electroencephalographic seizures and the impact of such events on functional outcome, as well as their association with the development of epilepsy, are set as secondary research objectives.

02

Conditions studied

  • Epilepsy

Browse trials for

03

In context

Epilepsy

1,848 studies on the registry are indexed under Epilepsy; 422 are open to participants now.

This study's planned enrollment of 100 is below the median of 112 across 540 observational studies indexed under Epilepsy.

Browse Epilepsy studies →

Lead sponsor

Attikon Hospital is the lead sponsor of 86 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Patients with acute ischemic or hemorrhagic stroke in whom it is not possible to perform an electroencephalogram within the first 7 days after the event, as well as patients who themselves or their legal representatives do not consent to participation, will be excluded from the study.

Eligibility criteria

Inclusion Criteria: Patients over 18 years of age with confirmed acute ischemic or hemorrhagic stroke are eligible for inclusion in the study. Patients whose clinical presentation mimics that of a stroke will be included until the diagnosis of stroke is ruled out, at which point they will be excluded from the study.

-

Exclusion Criteria:

-

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Target follow-up
2 Years
Patient registry
Yes

Groups and cohorts

  • Adult patients with acute ischemic or hemorrhagic stroke

    Other: Routine EEG

Interventions

  • OtherRoutine EEG

    The study is observational. No intervention is anticipated. Patients will be submitted to EEG recording within the first seven days of stroke

  • OtherRoutine EEG

    The study is observational

06

What researchers measure

Primary outcomes

  1. Incidence of post-stroke epilepsy

    Time frame: 4 years

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07190976
Lead sponsor
Attikon Hospital
Responsible party
Panagiota Eleni Tsalouchidou (Dr. med. Panagiota Eleni Tsalouchidou, Attikon Hospital) — Principal investigator
First posted
Sep 24, 2025
Start date
Mar 1, 2024
Primary completion
Sep 30, 2026 (estimated)
Completion
Sep 30, 2026 (estimated)
Last update
Sep 24, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion